Free tool
BHCUX and PHSYX: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between BHCUX and PHSYX
46% of their top holdings overlap by weight, with 10 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that PHSYX holds far more positions (115 vs 43), so it is broader beyond the top names.
| Holding | % of BHCUX | % of PHSYX |
|---|---|---|
| Eli Lilly & Co | 13.66% | 13.15% |
| Johnson & Johnson | 5.56% | 8.46% |
| Thermo Fisher Scientific Inc | 3.91% | 4.50% |
| UnitedHealth Group Inc | 3.28% | 6.93% |
| Edwards Lifesciences Corp | 2.64% | 2.80% |
| Vertex Pharmaceuticals Inc | 2.61% | 1.97% |
| AstraZeneca PLC | 2.49% | 4.67% |
| Merck & Co Inc | 2.48% | 4.88% |
| Gilead Sciences Inc | 1.99% | 2.63% |
| Intuitive Surgical Inc | 1.74% | 4.04% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized